Giuseppe Schillaci, Giacomo Pucci, Matteo Pirro. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Angiotensin II Type 1 Receptor Blockers/adverse effectsAngiotensin II Type 1 Receptor Blockers/therapeutic useBiphenyl Compounds/adverse effectsBiphenyl Compounds/therapeutic useBlood Pressure/drug effectsHeart Failure/drug therapyHumansHypotension/chemically inducedIrbesartanKidney Diseases/chemically inducedStroke VolumeTetrazoles/adverse effectsTetrazoles/therapeutic useTreatment Failure
Substances: See more » Angiotensin II Type 1 Receptor BlockersBiphenyl CompoundsTetrazolesIrbesartan
Year: 2009 PMID: 19301450
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245